Site work is underway for a vaccine manufacturing facility in a Dartmouth, Mass., business park that is set to develop new vaccines for COVID-19 and other infectious diseases.
Tonix Pharmaceuticals, based in Chatham, N.J., plans a 45,000-sq-ft clinical-scale manufacturing plant to be constructed as an existing building renovation in the New Bedford Business Park in Dartmouth that s expected to be operate in the first half of 2022. The clinical-stage biopharmaceutical company declined to reveal the cost of the project.